Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y; Japan Marrow Donor Program. Morishima Y, et al. Among authors: akatsuka y. Biol Blood Marrow Transplant. 2007 Mar;13(3):315-28. doi: 10.1016/j.bbmt.2006.10.027. Biol Blood Marrow Transplant. 2007. PMID: 17317585 Free article.
Exploration of the genetic basis of GVHD by genetic association studies.
Ogawa S, Matsubara A, Onizuka M, Kashiwase K, Sanada M, Kato M, Nannya Y, Akatsuka Y, Satake M, Takita J, Chiba S, Saji H, Maruya E, Inoko H, Morishima Y, Kodera Y, Takehiko S; Japan Marrow Donation Program (JMDP). Ogawa S, et al. Among authors: akatsuka y. Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):39-41. doi: 10.1016/j.bbmt.2008.11.020. Biol Blood Marrow Transplant. 2009. PMID: 19147076 Free article. Review. No abstract available.
Frequent inactivation of A20 in B-cell lymphomas.
Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, Asakura Y, Muto S, Tamura A, Iio M, Akatsuka Y, Hayashi Y, Mori H, Igarashi T, Kurokawa M, Chiba S, Mori S, Ishikawa Y, Okamoto K, Tobinai K, Nakagama H, Nakahata T, Yoshino T, Kobayashi Y, Ogawa S. Kato M, et al. Among authors: akatsuka y. Nature. 2009 Jun 4;459(7247):712-6. doi: 10.1038/nature07969. Epub 2009 May 3. Nature. 2009. PMID: 19412163
Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.
Sato-Otsubo A, Nannya Y, Kashiwase K, Onizuka M, Azuma F, Akatsuka Y, Ogino Y, Satake M, Sanada M, Chiba S, Saji H, Inoko H, Kennedy GC, Yamamoto K, Morishima S, Morishima Y, Kodera Y, Sasazuki T, Ogawa S; Japan Marrow Donor Program. Sato-Otsubo A, et al. Among authors: akatsuka y. Blood. 2015 Dec 17;126(25):2752-63. doi: 10.1182/blood-2015-03-630707. Epub 2015 Oct 2. Blood. 2015. PMID: 26432889 Free article.
Improving TCR affinity on 293T cells.
Ohta R, Demachi-Okamura A, Akatsuka Y, Fujiwara H, Kuzushima K. Ohta R, et al. Among authors: akatsuka y. J Immunol Methods. 2019 Mar;466:1-8. doi: 10.1016/j.jim.2018.11.010. Epub 2018 Nov 22. J Immunol Methods. 2019. PMID: 30468736 Free article.
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
Katsuyama N, Kawase T, Barakat C, Mizuno S, Tomita A, Ozeki K, Nishio N, Sato Y, Kajiya R, Shiraishi K, Takahashi Y, Ichinohe T, Nishikawa H, Akatsuka Y. Katsuyama N, et al. Among authors: akatsuka y. Nagoya J Med Sci. 2023 Nov;85(4):779-796. doi: 10.18999/nagjms.85.4.779. Nagoya J Med Sci. 2023. PMID: 38155626 Free PMC article.
169 results